Glaucoma 360: Drug delivery contact lens technology

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.


ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface diseases, during the 2020 Glaucoma 360 meeting in San Francisco, California.

See more Glaucoma 360 coverage here

Related Content:

GLAUCOMA 360GlaucomaTechnologyPharmacy
Refining surgical procedures with cloud-based analytical software
Outcomes of LASIK utilising new topography-integrated aberrometer
Micro-bypass stent implant during cataract surgery: lower IOP, fewer medications